The DSCSA applies to biopharmas, pharmacies, hospital dispensers, manufacturers, repackagers and third-party logistics companies.
Key takeaways
Mandatory electronic traceability at the unit level is required.
Failure to comply could mean business disruption or penalties for biopharmas.
The compliance deadline for the Drug Supply Chain Security Act is Nov. 27, 2023. In our helpful on-demand webcast, learn what biopharma and other life sciences companies need to know to ensure optimal systems and operational improvements are in place to address regulatory needs.
“Some companies may be behind schedule in implementing the latest traceability requirements due to a lack of fully understanding DSCSA requirements and the impact on the business, challenges with integrating organizational and third-party systems, or deficient or decreased resources. Qualified consultants can help organizations with assessment, tracking and tracing needs. However, biopharma companies should work with professionals experienced in the life sciences industry, as they will understand specific product, supply chain, and security issues, and ways to anticipate and address typical trouble spots within the sector.” − Countdown to DSCSA compliance
Gain a comprehensive understanding of compliance requirements, technology solutions, data management and collaborative strategies to enhance supply chain functionality.
Related insights
Subscribe to Life Sciences Insights
Knowledge is power. Stay up to date with key life sciences trends and timely insights, delivered straight to your inbox.
